Status:
COMPLETED
Surgical Outcomes, Quality of Life and Patient's Satisfactions With Phalloplasty
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Phalloplasty
Surgery
Eligibility:
MALE
20-73 years
Brief Summary
The phalloplasty is a reconstruction technique, consisting of the neophallus creation. It is performed in transgender patients in sex reassignment surgery, or in cismale patients to correct a congeni...
Eligibility Criteria
Inclusion
- Major patients
- Patients who have undergone a phalloplasty surgery in the University Lyon Sud Hospital or Croix Rousse Hospital, between 1 January 2007 and 31 October 2018
- Patients with at least one year of back on their surgery procedures
- Transgender patients whose reassignment surgery was validated by a minimum of three members of GRETTIS (Groupe de Recherche, d'Etude et de Traitement des Troubles de l'Identité Sexuelle), including a psychiatrist Or Patients cis males with congenital malformations, or having suffered a total or partial amputation of verge
- Patients who do not oppose orally to participate in the study, after information
- Patients who have given their consent for the audio recording for patients taking part in semi - directive interviews
Exclusion
- Minor patients or patients under legal protection
- Refusal to participate in the study
- No understanding of the French language
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 14 2020
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04314141
Start Date
May 15 2020
End Date
November 14 2020
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology Department, Hospices Civis de Lyon
Pierre-Bénite, France